Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network-Reference-Cited by-同舟云学术

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

Published:2022-04-14 Issue:6 Volume:57 Page:966-974
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Schenone Laurence^ORCID,Houillier Caroline,Tanguy Marie Laure,Choquet Sylvain^ORCID,Agbetiafa Kossi,Ghesquières Hervé,Damaj Gandhi^ORCID,Schmitt Anna,Bouabdallah Krimo,Ahle Guido^ORCID,Gressin Remy^ORCID,Cornillon Jérôme^ORCID,Houot Roch,Marolleau Jean-Pierre,Fornecker Luc-Matthieu,Chinot Olivier,Peyrade Frédéric,Bouabdallah Reda,Moluçon-Chabrot Cécile^ORCID,Gyan Emmanuel,Chauchet Adrien,Casasnovas Olivier^ORCID,Oberic Lucie,Delwail Vincent^ORCID,Abraham Julie,Roland Virginie,Waultier-Rascalou Agathe,Willems Lise,Morschhauser Franck,Fabbro Michel,Ursu Renata,Thieblemont Catherine^ORCID,Jardin Fabrice,Tempescul Adrian,Malaise Denis^ORCID,Touitou Valérie,Nichelli Lucia,Le Garff-Tavernier Magali,Plessier Aurélie,Bourget Philippe,Bonmati Caroline,Wantz-Mézières Sophie,Giordan Quentin,Dorvaux Véronique,Charron Cyril,Jabeur Waliyde,Hoang-Xuan Khê,Taillandier Luc,Soussain Carole^ORCID,Houillier Caroline,Choquet Sylvain,Hoang-Xuan Khê,Touitou Valérie,Soussain Carole,Cassoux Nathalie,Malaise Denis,Ursu Renata,Willems Lise,Ghesquières Hervé,Schmitt Anna,Chinot Olivier,Tabouret Emeline,Taillandier Luc,Blonski Marie,Houot Roch,Ahle Guido,Damaj Gandhi,Moluçon-Chabrot Cécile,Delwail Vincent,Fabbro Michel,Jardin Fabrice,Chauchet Adrien,Morschhauser Franck,Casasnovas Olivier,Gressin Rémy,Fornecker Luc-Matthieu,Abraham Julie,Marolleau Jean-Pierre,Tempescul Adrian,Agapé Philippe,Oberic Lucie,Gyan Emmanuel,Peyrade Frédéric,Gastinne Thomas,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01648-z.pdf

Reference38 articles.

1. Houillier C, Soussain C, Ghesquières H, Soubeyran P, Chinot O, Taillandier L, et al. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study. Neurology. 2020;94:e1027–e1039.

2. Omuro AMP, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, et al. Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol. 2005;62:1595–600.

3. Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, et al. Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology. 2013;81:84–92.

4. Schlegel U, Korfel A. Is whole-brain radiotherapy still a standard treatment for primary central nervous system lymphomas? Curr Opin Neurol. 2018;31:733–9.

5. Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol. 2013;31:3971–9.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review;Revue Neurologique;2023-12

2. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study;Neuro-Oncology;2023-12-01

3. Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma;Hematology;2023-08-07

4. New hopes in relapsed refractory primary central nervous system lymphoma;Current Opinion in Oncology;2023-07-18

5. First line treatments in primary central nervous system lymphomas in young patients;Current Opinion in Oncology;2023-07-18